Search
for
Sort by
Research 781–810 of 1000+
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
- Decision letter: Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
- Cytochrome P450: A Target for Drug Development for Skin Diseases
- Recent Advances in the Pathogenesis of Autoimmune Hair Loss Disease Alopecia Areata
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- Differential expression of steroid 5α-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer
- Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases
- Comprehensive RNA sequencing in primary murine keratinocytes and fibroblasts identifies novel biomarkers and provides potential therapeutic targets for skin-related diseases
- Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study
- Advances in Research of Hydrogel Microneedle-Based Delivery Systems for Disease Treatment
- The associations between irregular breakfast and late-night snacking with metabolic dysfunction-associated steatotic liver disease
- Could Vaccination against COVID-19 Trigger Immune-Mediated Inflammatory Diseases?
- Online search interest in long-term symptoms of coronavirus disease 2019 during the COVID-19 pandemic in Japan: Infodemiology study using the most visited search engine in Japan
- Proteomics as a tool to improve novel insights into skin diseases: what we know and where we should be going
- Epidemiological, clinical and economic burden of alopecia areata in Spain: a real-world retrospective study. The PETALO study
- The Role of the Gut Microbiome and Microbial Dysbiosis in Common Skin Diseases
- Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases
- The Spectrum of Health Domains Important to Lupus Patients Early Development of a Disease Activity Patient Reported Outcome.
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Microneedle-Mediated Transdermal Drug Delivery for the Treatment of Multiple Skin Diseases
- Unique Circulating MicroRNA Signatures Distinguish Severe Alopecia Areata from Other Inflammatory Skin Diseases
- Treatment patterns and healthcare resource utilization among patients with alopecia areata: A real‐world chart review in South Korea
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
- Effectiveness and safety of baricitinib in patients with moderate‐to‐severe refractory alopecia areata in real world: An open‐label, single‐center study
- Reflecting on the intersectionality of lived experiences of dermatological diseases and the WHO Framework for meaningful engagement of people living with noncommunicable diseases, and mental health and neurological conditions
- Free Testosterone Levels in Patients with Covid-19 and its Association with Disease Severity
- FGF-9 accelerates epithelial invagination for ectodermal organogenesis in real time bioengineered organ manipulation
- Proof-of-Principle Study of Inflammasome Signaling Proteins as Diagnostic Biomarkers of the Inflammatory Response in Parkinson’s Disease
- CYSTIC ENDOMETRIAL HYPERPLASIA AND BACTERIAL ENDOMETRITIS ASSOCIATED WITH AN INTRAUTERINE FOREIGN BODY IN A GUINEA PIG WITH OVARIAN CYSTIC DISEASE
- Understanding the role of prostaglandin E2 in regulating human platelet activity in health and disease